McKesson Co. (NYSE:MCK) Receives Consensus Recommendation of “Hold” from Analysts

Shares of McKesson Co. (NYSE:MCK) have received a consensus recommendation of “Hold” from the fourteen research firms that are covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $131.10.

A number of equities analysts recently weighed in on MCK shares. Zacks Investment Research lowered McKesson from a “hold” rating to a “sell” rating in a research report on Wednesday, April 3rd. ValuEngine lowered McKesson from a “sell” rating to a “strong sell” rating in a research report on Friday, March 1st. Finally, Wolfe Research initiated coverage on McKesson in a research report on Tuesday, April 2nd. They issued an “outperform” rating for the company.

In related news, CFO Britt J. Vitalone sold 832 shares of the stock in a transaction dated Friday, May 24th. The stock was sold at an average price of $129.17, for a total value of $107,469.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Lori A. Schechter sold 2,766 shares of the stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $133.59, for a total value of $369,509.94. The disclosure for this sale can be found here. Over the last three months, insiders sold 6,174 shares of company stock valued at $804,583. Company insiders own 0.87% of the company’s stock.

A number of institutional investors have recently made changes to their positions in the stock. Proficio Capital Partners LLC raised its stake in shares of McKesson by 161.2% during the 4th quarter. Proficio Capital Partners LLC now owns 222 shares of the company’s stock worth $25,000 after purchasing an additional 137 shares in the last quarter. Mark Sheptoff Financial Planning LLC purchased a new stake in shares of McKesson during the 1st quarter worth about $27,000. Smart Portfolios LLC purchased a new stake in shares of McKesson during the 1st quarter worth about $35,000. Investors Research Corp purchased a new stake in shares of McKesson during the 1st quarter worth about $36,000. Finally, Dubuque Bank & Trust Co. raised its stake in shares of McKesson by 106.7% during the 1st quarter. Dubuque Bank & Trust Co. now owns 341 shares of the company’s stock worth $40,000 after purchasing an additional 176 shares in the last quarter. 87.38% of the stock is owned by hedge funds and other institutional investors.

Shares of NYSE:MCK traded up $1.42 during midday trading on Wednesday, reaching $134.02. The company had a trading volume of 1,077,613 shares, compared to its average volume of 1,519,446. The company has a quick ratio of 0.58, a current ratio of 1.02 and a debt-to-equity ratio of 0.88. McKesson has a 1-year low of $106.11 and a 1-year high of $151.24. The firm has a market capitalization of $25.19 billion, a price-to-earnings ratio of 9.88, a price-to-earnings-growth ratio of 1.31 and a beta of 1.07.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, May 8th. The company reported $3.69 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.66 by $0.03. McKesson had a return on equity of 29.02% and a net margin of 0.02%. The business had revenue of $52.43 billion during the quarter, compared to analyst estimates of $53.14 billion. During the same quarter last year, the company posted $3.49 EPS. McKesson’s revenue for the quarter was up 1.6% on a year-over-year basis. Equities analysts predict that McKesson will post 14.14 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 1st. Investors of record on Monday, June 3rd will be paid a $0.39 dividend. This represents a $1.56 annualized dividend and a yield of 1.16%. The ex-dividend date is Friday, May 31st. McKesson’s dividend payout ratio is currently 11.50%.

About McKesson

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.

Featured Story: 52-Week High/Low

Analyst Recommendations for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit